When is second- or third- line therapy indicated in the treatment of hidradenitis suppurativa (HS)?

Updated: Aug 30, 2019
  • Author: Marina Jovanovic, MD, PhD; Chief Editor: William D James, MD  more...
  • Print

If improvement occurs, then therapy should be maintained as long as hidradenitis suppurativa lesions are present. If the patient fails to exhibit response, then consideration of second- or third-line therapy is required.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!